Research Scientist - Polymer Chemistry
About the job
- A PhD or MS with at least 2 years of experience in Chemistry, Chemical Engineering, Materials Science Engineering, or a related field.
- Background in organic, polymer, and analytical chemistry.
- Process development and optimization experience using design of experiments methodology, statistical analysis, and process control.
- Working familiarity with scientific software for design of experiments, data visualization, statistical analysis, simulation, or related uses.
- Strong problem-solving and analytical skills.
- Strong verbal, interpersonal, and written communication skills.
- Ability to work as a strong team player, be detail-oriented, and perform well under pressure.
- Develop technologies for high-resolution lithographic patterning of DNA and other biomolecules for applications in genomics and medicine.
- Design and develop improved fabrication chemistries, materials, and processes.
- Specify and procure components, materials, reagents, and systems.
- Collaborate with scientists and engineers in a cross-functional, multidisciplinary team.
- Calibrate and maintain process tools, instruments, and systems as necessary.
- Provide technical resources and operational support for troubleshooting manufacturing processes and testing manufactured products.
- Document experimental work, analyze data, and report and present results to technical and non-technical audiences.
- Support quality and safety standards and procedures.
- Experience with microfabrication, lithography, and resist processing is a plus.
About the company
Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.
Company Size
51-200
Company Stage
Series B
Total Funding
$24.3M
Headquarters
Palo Alto, California
Founded
2009
Get referred to Centrillion Technologies
See people who can refer or advise you
Simplify's Take
What believers are saying
- September 2026 site updates show active product marketing and service availability.
- Centrillion’s August 2026 AI messaging targets genome, cell, and tissue data buyers.
- The platform keeps multiple revenue paths: research chips, diagnostics, and sequencing services.
What critics are saying
- VirusHunter MVP remains only through Molecular Vision Laboratories as of August 2026.
- Centrillion shows no fresh 2025-2026 financing, suggesting constrained commercial scale.
- Illumina, Thermo Fisher, and Oxford Nanopore can crush adoption if chip volumes lag.
What makes Centrillion Technologies unique
- Centrillion’s September 2026 chips combine 50,000-2 million variants with sequencing workflows.
- VirusHunter pairs pathogen detection and whole-genome sequencing on ATOM and QuadCore chips.
- The company still owns a rare integrated stack: chips, assays, and clinical-lab services.
Help us improve and share your feedback! Did you find this helpful?